2016
DOI: 10.1093/toxsci/kfw194
|View full text |Cite
|
Sign up to set email alerts
|

FutureTox III: Bridges for Translation

Abstract: Future Tox III, a Society of Toxicology Contemporary Concepts in Toxicology workshop, was held in November 2015. Building upon Future Tox I and II, Future Tox III was focused on developing the high throughput risk assessment paradigm and taking the science of in vitro data and in silico models forward to explore the question-what progress is being made to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. This article reports on the outcome of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 37 publications
0
11
0
Order By: Relevance
“…How will the field deal with this? One approach could be to combine tests in biological networks guided by molecular mechanisms/AOPs (Jaworska et al 2015;Juberg et al 2016), or to use biological information across assays in form of a biological read across (Hartung 2016;Patlewicz and Fitzpatrick 2016;Strickland et al 2016a, b). Another old, but continuously present and topical issue (Judson et al 2016;Leist et al 2010) is the problem of cytotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…How will the field deal with this? One approach could be to combine tests in biological networks guided by molecular mechanisms/AOPs (Jaworska et al 2015;Juberg et al 2016), or to use biological information across assays in form of a biological read across (Hartung 2016;Patlewicz and Fitzpatrick 2016;Strickland et al 2016a, b). Another old, but continuously present and topical issue (Judson et al 2016;Leist et al 2010) is the problem of cytotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a large number of chemical substances need to be studied to identify the adverse effects on development, metabolic homeostasis, reproduction, cytotoxicity, etc. (Zhu et al, 2014; Bell et al, 2017; Insel et al, 2017; Juberg et al, 2017; Clark and Steger-Hartmann, 2018; Mortensen et al, 2018). Thus, high-throughput (HTP) assays and economical methods are required (Tollefsen et al, 2014; Chen et al, 2015; Wang et al, 2015; Richard et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…3 Target-level molecular/cellular data from high-throughput screening (HTS) assays, virtual tissue computer simulation models constructed from extant knowledge of embryology, and MPS technologies form a powerful triumvirate for characterizing potential developmental hazards in drug development and chemical safety. [4][5][6][7][8] This overview of opportunities and challenges in programming MPS models for children's health protection research is focused on novel testing strategies for developmental and reproductive toxicity. It is intended on one hand to the MPS community to highlight challenges and opportunities related to the developmental basis of health and disease, and on the other hand to the developmental biology community to note that validation criteria are being discussed in the MPS community that put these technologies on the horizon.…”
Section: Introductionmentioning
confidence: 99%